144 related articles for article (PubMed ID: 382531)
1. Individualized monitoring and modulation of immune reactivity using standardized antithymocyte globulin (ATG).
Thomas F; Mendez-Picon G; Thomas J; Lee HM
Transplant Proc; 1979 Jun; 11(2):1429-30. PubMed ID: 382531
[No Abstract] [Full Text] [Related]
2. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
[No Abstract] [Full Text] [Related]
3. A prospective randomized comparison of antilymphoblast globulin versus antithymocyte globulin for cadaver kidney transplantation.
Toledo-Pereyra LH; Bergren C; Mittal VK; Whitten JI; Baskin S; McNichol L
Transplantation; 1985 Oct; 40(4):448-50. PubMed ID: 3901446
[No Abstract] [Full Text] [Related]
4. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.
Cosimi AB; Wortis HH; Delmonico FL; Russell PS
Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887
[TBL] [Abstract][Full Text] [Related]
5. Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation.
Kountz SL; Butt KH; Rao TK; Zielinski CM; Rafi M; Schultz JR
Transplant Proc; 1977 Mar; 9(1):1023-5. PubMed ID: 325728
[No Abstract] [Full Text] [Related]
6. Use of antithymocyte globulin for reversal of acute allograft rejection.
Shield CF; Cosimi AB; Tolkoff-Rubin N; Rubin RH; Herrin J; Russell PS
Transplantation; 1979 Dec; 28(6):461-4. PubMed ID: 390784
[No Abstract] [Full Text] [Related]
7. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
[No Abstract] [Full Text] [Related]
8. Does suppression of T-RFC determine in vivo immunosuppressive effect of ATG?
Geis WP; Giacchino JL; Buckingham JM; Bansal VK; Iwatsuki S; Kerman RH; Ing TS; Hano JE
Transplant Proc; 1979 Jun; 11(2):1433-4. PubMed ID: 382533
[No Abstract] [Full Text] [Related]
9. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
[No Abstract] [Full Text] [Related]
10. Intravenous antilymphocyte globulin in human cadaveric renal allotransplantation. Clinical and immunologic observations.
Collste LG
Acta Chir Scand; 1972; 138(8):765-74. PubMed ID: 4565721
[No Abstract] [Full Text] [Related]
11. Lung transplantation: improved survival of canine lung allografts perfused with antithymocyte globulin (ATG).
Toledo-Pereyra LH; Condie RM; Hau T; Simmons RL; Najarian JS
Bol Asoc Med P R; 1976 Sep; 68(9):234-8. PubMed ID: 802385
[No Abstract] [Full Text] [Related]
12. Antithymocyte globulin in cadaver renal grafts: prophylaxis and antirejection therapy with three different preparations.
MacDonald AS; Belitsky P; Lannon SG; Cohen A; White J
Transplant Proc; 1982 Dec; 14(4):631-4. PubMed ID: 6762719
[TBL] [Abstract][Full Text] [Related]
13. Antithymocyte globulin (ATG) and trenimon (TR): effects on T cells and graft rejection.
Beatty JD; Friesen E; Linford JH; Israels LG
Surg Forum; 1977; 28():327-9. PubMed ID: 364726
[No Abstract] [Full Text] [Related]
14. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring.
Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D
Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170
[TBL] [Abstract][Full Text] [Related]
15. Effective monitoring and modulation of immune reactivity in allograft recipients.
Thomas F; Lee HM; Thomas J; Mendez-Picon G
Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():20-6. PubMed ID: 801063
[TBL] [Abstract][Full Text] [Related]
16. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
[No Abstract] [Full Text] [Related]
17. Treatment of multiple rejection episodes with ALG or ATGAM after cadaveric renal transplantation.
Toledo-Pereya LH; Whitten J; Baskin S; McNichol L; Thavarajah K; Lin W
Bol Asoc Med P R; 1984 Jul; 76(7):293-6. PubMed ID: 6383417
[No Abstract] [Full Text] [Related]
18. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital.
Delmonico FL
Transplant Proc; 1984 Aug; 16(4):979-82. PubMed ID: 6380062
[No Abstract] [Full Text] [Related]
19. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M
Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564
[TBL] [Abstract][Full Text] [Related]
20. Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month.
Daudu P; Wright K; Geelhoed GW
Am Surg; 1980 Dec; 46(12):697-707. PubMed ID: 7004286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
